The NPPA letter was issued to GSK on Wednesday.
Sun Pharma's market capitalisation stood at Rs 100,050 crore on December 5, with its share price closing at Rs 417 a piece - lowest since March 2013.
The S&P BSE Sensex has rallied about 28 per cent in 2014, after formation of a stable government at the Centre.
India is the second largest buyer of Iranian crude, after China.
market, was today seized from an illegal drug manufacturing unit in Jalgaon district in north Maharashtra and six persons were arrested, Directorate of Revenue Intelligence officials said.
In August, RBI allowed 11 business houses to start a payments bank.
He said countries should work for promoting open and inclusive cooperation for win-win outcomes.
The board would take a decision on these applications on February 20.
In the broader market, the S&P BSE Midcap added over 1% to finish at record closing high
Out of nearly 30 public sector undertakings and assets under 'strategic sale' plan, only the ONGC-HPCL plan has been completed
We present our alphabet of 2020, pulling in everything you'll remember about this year we'd rather forget.
The 'Make in India' vision cannot survive in the long-term without concrete measures to build a concurrent 'Create in India' movement.
In 2014, Sun Pharma agreed to buy Ranbaxy -- which was then controlled by Daiichi.
'For the last two months, the menace of stray dogs has gone to scary proportions in Kerala' 'What will you do if you cannot walk on the road without fear?'
.jpg)
Firms are mandated to change prices of medicines within 45 days of NPPA's notification.
There is a sense of relief in Beijing that Modi will be at the helm of affairs in Delhi at a critical juncture in the geopolitics of the region, says Ambassador M K Bhadrakumar.
Fund managers weren't too worried in 2014, as it was a year of positive surprises.
If currency controls are maintained indefinitely, popular support for Narendra Modi's demonetisation will turn into dislike, warns Devangshu Datta.
Jaitley's team presents a quintessential mix of foreign-educated, intellectual technocrats and seasoned bureaucrats
The broader markets outperformed the benchmark indices- BSE Midcap and Smallcap indices gained 0.4% each
Investor lobbies and tax lawyers estimate the bill for international funds and banks could be as high as $8 billion
Tata Motors was the top gainer on better-than-expected June quarter revenues
In a meeting with the commerce minister, India Inc hammered Sharma on the collapse of investments, structural nature of the current account deficit and stagnant growth in agriculture.
The Indian government headed by Prime Minister Manmohan Singh, who is known as the architect of the country's liberalisation and economic reforms, is inching towards a "protectionist" regime, top American experts have told US lawmakers.
Prosecutors unveiled charges against Valvani alleging he fraudulently made $25 million by getting advance information about US Food and Drug Administration approvals of generic drug applications
Sources indicated defence and national security initiatives.
Mitra Biotech's personalised cancer therapy could be a game changer in the field of cancer medicine.
In 2013, Daiichi had launched the arbitration proceedings in Singapore.
Foreign Trade Policy: More incentives for exports, focus on ease of trading
Financials were among the top losers along with Sun Pharma and index heavyweight Reliance Industries
Three IPO documents were recorded after the new govt took charge - Adlabs, Lavasa Corp and Monte Carlo Fashions.
'Without it, it is going to be much, much, much, much worse.' 'In the meantime, we really need to work on a sort of war footing, given that it is a natural disaster, provide relief, provide essentials, till we get biological herd immunity, we need to get economic immunity, and also social immunity.'
Move to address MNCs' taxation woes; UK likely to be the next.
Sebi first began looking into the matter last month.
The Pradhan Mantri Jan Aushadhi Yojana or PMJAY has not been a runaway success by any yardstick. Not all stores are running, and many are poorly stocked.
Sun maintained it would retain the best of both organisations to build a global pharma company.
Nifty50 surged 87 points to end at 8,157, highest closing levels since Oct 29, 2015.
Think beyond engineering and medicine.
Sun-Ranbaxy are keen to complete the merger process.
PSU bank shares were the top gainers on hopes of a rate by the RBI on easing consumer inflation
© 2026 Rediff.com - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances